Micafungin Pharmazac 100 Mg

Micafungin, the active ingredient in Micafungin Pharmazac 100 Mg, is an echinocandin presented as a 100 mg injectable solution for intravenous use. It treats invasive candidiasis and related fungal infections in immunocompromised patients.

GNH USA supplies Micafungin Pharmazac 100 Mg as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, transplant centres, oncology centres and pharmacies worldwide.

Micafungin is an echinocandin antifungal used to treat serious Candida infections.

- Invasive candidiasis: effective for bloodstream and deep‑tissue Candida infections. - Esophageal candidiasis: clears fungal infection of the esophagus. - Prophylaxis in hematopoietic stem cell transplantation: prevents Candida infection in transplant recipients. - Candida peritonitis and intra‑abdominal infections: treats intra‑abdominal Candida infections.

Micafungin may cause a range of adverse reactions, varying from mild to severe.

Common Side Effects: - Fever: transient elevation of body temperature. - Nausea: mild to moderate upset stomach. - Headache: occasional mild headache. - Elevated liver enzymes: mild increase in ALT/AST. - Phlebitis at infusion site: irritation or inflammation.

Serious or Rare Side Effects: - Hepatotoxicity: significant liver injury. - Severe hypersensitivity: rash, angioedema, or anaphylaxis. - Renal impairment: acute kidney injury. - Neutropenia: marked reduction in neutrophil count.

When using Micafungin, clinicians should consider several safety and handling precautions. - Renal function: assess baseline kidney function before therapy. - Hepatic function: monitor liver enzymes during treatment. - Drug interactions: review concomitant medications for potential interactions. - Pregnancy: avoid use unless benefits outweigh potential risks, as safety is unknown. - Infusion reactions: monitor patient during IV administration for signs of reaction. - Store at 2-8 °C: keep refrigerated, protect from light, do not freeze or shake.

Micafungin can interact with other medicines, affecting efficacy or safety.

Major Interactions (Avoid): - Cyclosporine: increased micafungin exposure may raise toxicity risk. - Rifampin: may reduce micafungin plasma levels, decreasing effectiveness.

Moderate Interactions (Monitor Closely): - Azole antifungals (e.g., fluconazole): may alter micafungin metabolism. - Statins (e.g., simvastatin): potential for increased statin levels. - Immunosuppressants (e.g., tacrolimus): monitor levels due to possible changes.